A Study to Investigate the Absorption, Metabolism and Excretion of [14C]ASP8273 in Subjects With Solid Tumors

Summary

This is a study to investigate the absorption, metabolism and excretion of \[14C\] labeled ASP8273 in subjects with solid tumors harboring EGFR mutations (per local testing). This study consists of two parts (A and B).

Timeline

Start

2016-11-15

Primary completion

2016-11-15

Completion

2016-11-15

Outcome

Outcome not reported

Stopped (Enrollment): “Following recommendation by SOLAR Study IDMC, Astellas closed enrollment in ASP8273 studies.”

Drugs

Indications